CYTOR and acute myeloid leukemia: discovered that LINC00152 is crucial for LSC self‐renewal; knockdown of LINC00152 inhibits colony formation of CD34+ AML cells and increases their chemotherapeutic sensitivity, although the molecular mechanisms regulating LSC self‐renewal remain unclear.